Allbirds just sold for $39M.

That's not the interesting number. The interesting number is $43M, the estimated value of their inventory at last count.

American Exchange paid $39M for the IP, brand, customer relationships, and all remaining inventory. The inventory alone was worth more than the purchase price. That's not a brand acquisition. That's a liquidation with a logo attached.

The capital timeline is worth sitting with: $200M+ in private capital, $348M raised at IPO, $4B+ peak valuation, $550M+ consumed. Revenue peaked at $297M in 2022, fell to $152M by 2025. The business was burning $0.45 of every dollar of revenue on the way out.

Here's what nobody is saying clearly: when a consumer brand reaches this point, cash depleting, revenue declining, burn rate compounding, the buyer knows the inventory is the floor. The brand, the IP, the customer list? Optionality they're getting for free.

Distressed consumer exits don't get priced on revenue multiples or brand equity narratives. They get priced on what's left on the balance sheet. In this case: $43M of inventory, purchased for $39M.

The amount raised had nothing to do with the outcome. The burn rate did.

One investor. One check. $14.5M in 2020.

That's the entire institutional capital history of the leading wellness shot brand in America.

Prelude Growth Partners wrote that check, took a minority stake, and held for five years. No follow-on rounds. No syndicate. No bridge notes. This week, Bansk Group acquired a majority stake in So Good So You for an estimated $350M.

The business they bought: $100M+ in revenue in 2025, fivefold growth in four years, category leader across US multi-outlet channels, 10,000+ stores, 2 million shots per week. If Prelude held 20–30% of the company, they returned $70–100M on a $14.5M check. One investment. Five years. Clean exit.

The founder story deserves equal attention. Rita Katona, a Hungarian immigrant who moved to Minneapolis and saw the food-as-medicine gap a decade before McKinsey was writing reports about it, retains equity and a board seat.

Some consumer brands raise three times that capital to get to half the revenue. The comparison with Allbirds is almost uncomfortable: So Good So You raised roughly 38x less and exited for roughly 9x more.

Capital discipline isn't a constraint. It's the strategy. And Prelude's model, one minority check, patient hold, clean exit, is starting to look like a template worth studying.

A former pro snowboarder built a deodorant brand around fragrance and just sold it for $500M+.

Not function. Not clean ingredients. Fragrance.

Two weeks ago on this podcast, Sam Kaplan of Five Seasons Ventures laid out his thesis: take the boom in niche fragrance and apply it to adjacent categories. He named Touchland in hand sanitizer, Sol de Janeiro in body care, Tallow & Ash in laundry, Purdy & Figg in surface cleaners. This week, Advent paid $500M+ for Salt & Stone. Sam called it.

The business: founded in 2017 by Nima Jalali. Four franchise scents, Santal & Vetiver, Bergamot & Hinoki, Black Rose & Oud, Neroli & Basil, running across deodorant, body mist, body wash, and lotion. The fragrance isn't a feature. It's the identity. Body care as a fragrance delivery system. One deodorant sold every five seconds.

$165M in revenue in 2025. Double-digit growth across every channel. DTC at 40% of sales. 1,700+ retail doors across 40 countries. Almost all of it built without institutional capital, one minority round from Humble Growth in August 2024. Eighteen months later, Humble is out into $500M+. Jalali retains equity and stays as CEO.

The strategic logic for Advent: fragrance-led body care is an acquisition thesis, not just a brand strategy. The consumer has already proven she'll pay a premium for a scent she identifies with across multiple SKUs. The repeat purchase mechanic is built into the identity, not the formulation. That's a more durable moat than most PE firms get to underwrite.

Three exits this week, Allbirds, So Good So You, Salt & Stone, and the capital efficiency ranking maps almost perfectly to the exit quality ranking. The brands that raised the least, relative to what they built, returned the most.

Most founders think getting the PO is the hard part. It's not. It's getting the product to actually sell through once it hits shelf.

Erin Wall has lived this from every angle, nearly a decade as a merchant at Target, years as a broker watching founders' eyes glaze over when she explained they needed $6M of inventory by next quarter, and now as President of Lunr Capital, a firm built specifically to fill that gap.

This was one of the more practically useful conversations I've had on the pod. Erin doesn't deal in theory, she's seen every version of this go wrong.

Five things that stuck:

Your credibility in a buyer meeting dies before you start if you don't know your numbers. Merchants are underwriting your ability to execute, not just your product. Walk in without a clear view of your margins, your velocity assumptions, and your replenishment timeline and the conversation is already over.

Margins need to work on day one. Not "once you get to scale." The retail margin trade-off only gets harder as you add complexity, more SKUs, more doors, more chargebacks. If the unit economics don't work at launch, scale makes them worse, not better.

How Lunr underwrites is worth understanding. They touch products, connect directly to bank accounts, and model real contribution margins, not the pitch deck version. The underwriting is grounded in what the business actually looks like, not what the founder believes it will become.

Your debt partner matters as much as your equity investor. The wrong debt structure in retail can be existential. The right one gives you the runway to actually sell through. Choosing a capital partner who understands retail seasonality, chargebacks, and sell-through cycles is not a secondary decision.

The Walmart story is the real lesson. Six months of inventory. A formulation that didn't sell. The path out of that situation is not obvious, and most founders have no idea it's coming when they sign the PO.

The thread connecting Erin's work to the three exits above: the capital decisions that determine outcomes in consumer aren't made at the fundraising stage. They're made in the inventory commitments, the retail terms, the debt structure, and the burn decisions that follow. Getting the PO is the beginning of the capital problem, not the end of it.

🎧 Watch on YouTube, listen on Spotify.

Thanks to sponsors:
⚙️ Visit Recharge - the go-to solution for subscriptions and payments
🧾 Check out Aftersell - boost AOV and increase sales

That’s it for this week.
If you liked this issue, forward to a friend who obsesses over brand strategy, capital flows, or exit timing.

In the Money – following the flow of capital in consumer

P.S. We love talking to brands interested in exiting in the next 3-18 months. If you know of any brands interested in exiting, or any firms trying to help port cos manage turnarounds, we'd love to share a POV.

fan [at] thehedgehogcompany.com